Moderna says COVID-19 vaccine works on Delta variant
It also worked on the Beta, Eta and other two first identified in Uganda and Angola
Company
Moderna Inc
MRNA:[TICKER]
Moderna Inc is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
102 stories · page 5 of 6
Coronavirus: Moderna says tweaked vaccine works against variants, two BioNTech/Pfizer doses give 95% protection
Moderna also turned its first quarterly profits after the jab delivered US$1.7bn of sales
Moderna boosts investments to reach 3bn doses capacity in 2022
The biotech also raised its 2021 supply forecast to 800mln-1bn doses
Coronavirus: England offers jabs to over-45s after hitting vaccination target, begins Moderna Inc rollout
The government aims to offer all adults a vaccine by the end of July
Archive
Dow tanks 560 points, Nasdaq has worst single-day since October as yield rates rise
Apple, Amazon, Facebook and Alphabet all lost more than 3%
Coronavirus: Pfizer vaccine proves highly effective in real-world study, Moderna eyes 2,000% rise in revenue
Moderna is to start the first phase of clinical trials for the version of the vaccine designed to target the South African variant
Coronavirus: Moderna says jab effective against UK, South African variants, Merck drops candidates after unsuccessful trials
The latest developments in the theme of COVID-19 vaccines
Coronavirus: UK approves Moderna vaccine and to impose negative test for travellers, BioNTech/Pfizer jab may work against new strain
Because of Brexit, the UK is not expected to receive the first Moderna deliveries until April
BioNTech, Moderna say approved COVID-19 vaccines should protect against new strain
Meanwhile, the AstraZeneca/Oxford vaccine may receive approval as early as next week
Coronavirus vaccines: Moderna nears US approval, Valneva starts trials in UK as rollout in full steam
Meanwhile in China, Fosun Pharmaceutical has agreed to buy at least 100mln doses of the Pfizer/BioNTech jab for £450mln
Moderna COVID-19 vaccine described as highly effective by FDA scientists
Unconfirmed reports in the US press suggested the final FDA decision would be announced on Friday.
Moderna starts late-stage COVID-19 vaccine trials on teenagers
In other vaccine news, the EU regulator suffered a cyber-attack and the documents related to the Pfizer/BioNTech jab were accessed
Moderna expected to see US$10-15bn from COVID-19 vaccine sales, says Morgan Stanley
Analysts said the revenue forecasts are priced in the recent rally
Moderna boss says its COVID-19 vaccine should be given to vulnerable
The vulnerable and elderly should get its vaccine says chief executive and healthy people should get another vaccine.
Archive
US stocks rally on Moderna vaccine potential, economic recovery
The Dow and S&P 500 posted all-time closing highs as the Nasdaq lags
Moderna says COVID-19 vaccine candidate is 94.5% effective
An independent safety monitoring board confirmed the statistics based on interim results from a late-stage trial
Which Covid vaccines are in phase III? A look at Moderna Therapeutics and the chasing pack
Moderna’s potential treatment uses a different tactic to traditional vaccines: mRNA
Which COVID-19 vaccines are in phase III? A look at Moderna Therapeutics and the chasing pack
Moderna CMO Tal Zaks explained to Stephen Dubner on the Freakonomics Radio podcast just how and why his team might succeed where others have thus far failed
Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward
The firm said the vaccine candidate, known as mRNA-1273, was safe and had built up an immune response in all 45 participants in the first phase of clinical trials
Archive
Tesla China Plant Might Have Come to the Rescue Last Quarter
“The lesson learned by now is that TSLA shares tend to ‘work’ when something new has launched,” Jeffrey Osborne, a Cowen Inc. analyst with the equivalent of a sell rating on the stock, said in a report Tuesday. “At this point both the Model